Lethality of H1N1 Virus Drops to “Non-Epidemic Resting Levels” in Current Cycle – Virus’ Infectivity Remains Increased; New Faster-Developed Synthetic Replikin Vaccines Found Effective, FluForecast(R) Gives Advance Warning of Strain-Specific Outbreaks and Cessation Biotech firm Replikins Ltd., which has analyzed the H1N1 virus’ genomic data from the 1918 pandemic through the prediction, outbreak, and progress [...]
Both Live, Attenuated Influenza Vaccine (LAIV) and Trivalent Inactivated Vaccine (TIV) provide Protection against novel A/H1N1, especially against severe disease Immunization with either live attenuated influenza vaccine (LAIV, also known as FluMist®), or trivalent inactivated influenza vaccine (TIV), appears to offer a protection (~ 45%) against the novel A/H1N1 virus, the cause of the present [...]
New Atlas Project to Deepen Scientific Understanding of Malignant Brain Tumors; Opens the Door for Improved Patient Care and Treatment Options A major collaborative research project focused on mapping the gene activity in brain tumors was launched, The goal of the research, known as the Ivy Glioblastoma Atlas Project (GAP), is to unlock the secrets [...]
Only three states require exams, many children remain untreated, creating a new public health concern, according to report from National Commission on Vision and Health Even though universal comprehensive eye exams for children prior to starting school would result in more children being diagnosed and successfully treated for vision problems and eye diseases, requirements vary [...]
Data shows 82% of patients have neuropathy onset during their 30s-60s A new national Neuropathy Association poll of peripheral neuropathy patients finds that the majority of respondents had their neurological disease begin during their prime adult years, with 82% experiencing neuropathy’s onset between the ages of 30-69. “Peripheral neuropathy does not discriminate: it affects all [...]